Imagion Biosystems Limited has released “Pro-Rata Renounceable Rights Issue”. Highlight of this issue include:
- Funds to complete the manufacture of nanoparticle material and initiate a first-in-human study (where sufficient capital is raised) and for general working capital
- 2-for-5 pro-rata renounceable rights issue at an issue price of $0.01 per share to raise a up to approximately $2.04 million
- Discount of 38% to the 30 day VWAP
- With every New Share, shareholders will receive a free attaching New Option
- New Options will have Exercise Price of 3.0 cents and a term of three years
- Shortfall facility to enable applications for additional shares
Read the Pro-Rata Renounceable Rights Issue.
